openPR Logo
Press release

Transcatheter Aortic Valve Replacement Market Forecast and Innovations 2034

03-19-2025 11:19 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Transcatheter Aortic Valve Replacement (TAVR) Market

Transcatheter Aortic Valve Replacement (TAVR) Market

On March 19, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Transcatheter Aortic Valve Replacement (TAVR) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The Transcatheter Aortic Valve Replacement (TAVR) market is experiencing rapid growth driven by the rising prevalence of cardiovascular diseases. TAVR is a minimally invasive procedure offering faster recovery and improved outcomes compared to traditional surgery. Increasing adoption of TAVR in aging populations and high-risk patients is boosting demand. Technological advancements are enhancing device precision, durability, and procedural safety. Key players are investing in next-generation valves for improved performance and reduced complications. Rising healthcare investments and improved access to surgical care are further fueling market expansion.

The global transcatheter aortic valve replacement (TAVR) market is expected to grow at 22% CAGR from 2025 to 2034. It is expected to reach above USD 26 billion by 2034 from USD 4.34 billion in 2024.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response):

https://www.exactitudeconsultancy.com/reports/3811/transcatheter-aortic-valve-replacement-tavr-market/#request-a-sample

This report is also available in the following languages: Japanese (経カテーテル大動脈弁置換術 (TAVR)), Korea (경피적 대동맥 판막 교체(TAVR)), china (经导管主动脉瓣置换术 (TAVR)), French (Remplacement valvulaire aortique par voie transcathéter (TAVR)), German (Transkatheter-Aortenklappenersatz (TAVR)), and Italy (Sostituzione della valvola aortica transcatetere (TAVR)), etc.

Key Players in This Report Include: CryoLife, Inc., Abbott; Micro Interventional Devices, Inc., Boston Scientific Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., Edwards Lifesciences Corporation, Medtronic, Auto Tissue Berlin GmbH, lepumedical.com, Neovasc Inc., TTK HealthCare and JenaValve Technology, Inc and other.

👉 Purchase Now Up to 30% Discount on This Premium Report @

https://exactitudeconsultancy.com/purchase/?currency=USD&type=single_user_license&report_id=3811

The Global Transcatheter Aortic Valve Replacement (TAVR) Market segments and Market Data Break Down are illuminated below:

Global Transcatheter Aortic Valve Replacement (TAVR) Market by Procedure, 2024-2034, (USD Million)

Transfemoral Implantation

Transapical Implantation

Transaortic Implantation

Global Transcatheter Aortic Valve Replacement (TAVR) Market by End User, 2024-2034, (USD Million)

Hospitals

Ambulatory Surgical Centers

Others

The latest version of the report (Version 2025) provides analysis through various business metrics including:

- Pestle Analysis

- 4 Ps (Product, Price, Place, and Promotion)

- Porters Analysis

- SWOT Analysis

- Competitive Landscape

- Company Market Share Analysis (US$ Mn)

📍 Geographical Landscape of the Transcatheter Aortic Valve Replacement (TAVR) market:

The Transcatheter Aortic Valve Replacement (TAVR) Market report offers detailed insights into the market landscape, which is further categorized into sub-regions and specific countries. This section of the report not only highlights the market share for each country and sub-region but also identifies potential profit opportunities within these areas.

» North America (United States, Canada, and Mexico)

» Europe (Germany, France, UK, Russia, Italy)

» Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

» Latin America (Brazil, Argentina, Colombia)

» Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

📍 Browse Full Report With TOC & List Of Figure:

https://exactitudeconsultancy.com/reports/3811/transcatheter-aortic-valve-replacement-tavr-market/

Key Market Study Points

Growth rate and market size projections from 2025 to 2034

Key factors driving and restraining market growth

Market Trends shaping the future of screw conveyors

Competitive analysis and key player strategies

Technological innovations and their impact on market expansion

Reasons to buy:

👉 Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

👉 Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

👉 Classify potential new clients or partners in the target demographic.

👉 Develop tactical initiatives by understanding the focus areas of leading companies.

👉 Plan mergers and acquisitions meritoriously by identifying Top Manufacturers.

👉 Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.

👉 Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Our team is available 24/7 to assist and support our customers through reliable research.

Can I modify the scope of the report and customize it to suit my requirements?

Yes. Modified, multi-dimensional, in-depth, and high-quality insights empower our customers to seize market opportunities, tackle challenges, craft effective strategies, and act swiftly-gaining a competitive edge with ample time and space to succeed.

- country-level analysis for the 5 countries of your choice.

- competitive analysis of 5 key market players.

- 40 free analyst hours to cover any other data point.

Discover More: Visit Our Website for Additional Reports!

Access Control Market

https://www.openpr.com/news/3757868/latest-access-control-market-securing-spaces-with

Antibody Production Market

https://www.openpr.com/news/3758228/latest-antibody-production-market-advancing-research

Biodegradable Paper & Plastic Packaging Market

https://www.openpr.com/news/3760411/biodegradable-paper-and-plastic-packaging-market-supporting

Color Concentrates Market

https://www.openpr.com/news/3760563/latest-color-concentrates-market-advancing-plastic

Gyroscope Market

https://www.openpr.com/news/3765224/gyroscope-market-driving-precision-and-stability-in-navigation

Infrastructure As A Service (Iaas) Market

https://www.openpr.com/news/3765349/latest-infrastructure-as-a-service-iaas-market

Medical Foam Market

https://www.openpr.com/news/3767397/latest-medical-foam-market-shaping-comfort-and-safety-across

OLED Market

https://www.openpr.com/news/3767507/latest-oled-market-redefining-display-technologies-with

Polyolefin Pipe Market

https://www.openpr.com/news/3767673/latest-polyolefin-pipe-market-enabling-advanced

SAP Success Factors Service Market

https://www.openpr.com/news/3769998/latest-sap-success-factors-service-market-growing-with-demand

Visit More Sites:

https://www.thehealthanalytics.com/

https://www.analytica.global/

About Us:

Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

Media Contact:

Exactitude Consultancy

PHONE NUMBER: +1 (704) 266-3234

EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transcatheter Aortic Valve Replacement Market Forecast and Innovations 2034 here

News-ID: 3924191 • Views:

More Releases from Exactitude Consultancy

Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at 8.1% CAGR
Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at …
Introduction Hypertrophic cardiomyopathy (HCM) is a genetic heart disorder characterized by abnormal thickening of the heart muscle, which can impair blood flow and increase the risk of arrhythmias, heart failure, and sudden cardiac death. Once managed primarily through beta-blockers, calcium channel blockers, and invasive procedures, the HCM treatment landscape has expanded with the approval of targeted therapies such as cardiac myosin inhibitors. Growing awareness of genetic cardiovascular diseases, advances in molecular diagnostics,
Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion by 2034, Growing at 10.3% CAGR
Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion …
Introduction Biologics-including monoclonal antibodies, vaccines, recombinant proteins, and advanced therapies-are at the forefront of modern medicine. Their development, however, requires significant expertise, advanced infrastructure, and compliance with stringent regulatory standards. To meet these demands, pharmaceutical and biotechnology companies are increasingly outsourcing to Contract Research Organizations (CROs) specializing in biologics. Biologics CROs provide services spanning discovery, preclinical research, clinical trials, bioanalytical testing, and regulatory consulting. With the rise of biologics, biosimilars, and advanced
Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% CAGR
Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% …
Introduction Niemann-Pick disease (NPD) is a group of rare, inherited lysosomal storage disorders caused by mutations that disrupt lipid metabolism, leading to progressive neurological decline, organ dysfunction, and premature death. The condition is categorized into several subtypes (A, B, and C), each varying in severity and progression. Historically, treatment has been limited to palliative and supportive care. However, the landscape is changing rapidly with the development of enzyme replacement therapies (ERT), substrate
PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: Novartis AG & GSK
PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: N …
The fight against cancer and neurodegenerative diseases has brought the spotlight on the PERK (Protein kinase RNA-like endoplasmic reticulum kinase) pathway, a critical regulator of the unfolded protein response. PERK inhibitors are designed to modulate this pathway, reducing stress-induced cell death and playing a pivotal role in oncology, neurodegenerative research, and metabolic disorders. As precision medicine continues to gain traction, PERK inhibitors are attracting significant attention from both biotech firms

All 5 Releases


More Releases for TAVR

TAVR Market Leads Heart Health Revolution with Surging Innovations
The global transcatheter aortic valve replacement (TAVR) market size is expected to be valued at USD 4.28 billion in 2024 and reach USD 10.02 billion by 2029, growing at a CAGR of 18.50 % from 2024 to 2029. Transcatheter aortic valve replacement is a procedure that replaces a diseased aortic valve with a transcatheter aortic valve, which regenerates the blood-pumping function of the heart aortic valve. Global TAVR Market Report Scope: • Market Size
Transcatheter aortic valve replacement (TAVR) Market Current Business Trends & G …
Demand Analysis of Transcatheter Aortic Valve Replacement (TAVR) Market Overview: The Transcatheter aortic valve replacement (TAVR) Market is predicted to grow at a moderate CAGR of 22% during the forecast period covering 2022 to 2029. Transcatheter aortic valve replacement (TAVR) Market share is estimated to reach a value of nearly US$ 26 billion by 2029. The "Transcatheter Aortic Valve Replacement (TAVR) Market" think about 2022, the industry landscape is secured from driving
Transcatheter Aortic Valve Replacement (TAVR) Market Status and Global Outlook 2 …
Global Transcatheter Aortic Valve Replacement (TAVR) Market Research Report:(US$ 900) This Report Provides an overview of the Transcatheter Aortic Valve Replacement (TAVR) market, containing global revenue, global production, sales, and CAGR. Also describe Transcatheter Aortic Valve Replacement (TAVR) product scope, market overview, market opportunities, market driving force, and market risks. The forecast and analysis of the Transcatheter Aortic Valve Replacement (TAVR) market by type, application, and region are also presented. The next part of the report provides
Transcatheter Aortic Valve Replacement (TAVR) Global Market 2019
Press Release – 30 Jan 2019 Research and Development News -- . . Latest Update "Global Transcatheter Aortic Valve Replacement (TAVR) Market (Value, Volume): Analysis By Type of Approach (Transfemoral, Transapical), By Region, By Country (2018 Edition): Forecast to 2023 - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, France, United Kingdom, India, Japan China, Brazil, South Africa)" with Industries Survey | Global Current Growth and Future. ' ' A
Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Factors reveale …
According to the report “Global Transcatheter Aortic Valve Replacement (TAVR) Market,” published by Market Data Forecast, the global market is projected to reach USD 4.29 billion by 2021, at a CAGR of 18.50% from 2016 to 2021. Transcatheter aortic valve replacement (TAVR) is described as minimally invasive procedure replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery for the benefit of high
North America Transcatheter Aortic Valve Replacement (TAVR) Market Size, share a …
According to the report North America Transcatheter Aortic Valve Replacement (TAVR) Market, published by Market Data Forecast, the global market is projected to reach USD 1.34 billion by 2021, at a CAGR of 16.80% from 2016 to 2021. For full report refer to http://www.marketdataforecast.com/market-reports/north-america-transcatheter-aortic-valve-replacement-market-358/ Transcatheter aortic valve replacement (TAVR)is described as minimally invasive procedure replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery